Daix (France), New York City (New York, United States), January 24, 2025 - Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva” or the "Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis ("MASH”) and other diseases with significant unmet medical needs, today announced the half-year report of its liquidity contract with Kepler Cheuvreux.
Under the liquidity contract granted to Kepler Cheuvreux by Inventiva, the following resources were available in the liquidity account as of 31 December 2024:
- Cash: € 349,630.55
- Number of shares: 113,452
- Number of executions on buy side on semester: 1,281
- Number of executions on sell side on semester: 1,366
- Trade volume on buy side on semester: 215,444 shares for € 477,452.69
- Traded volume on sell side on semester: 231,651 shares for € 538,913.35
At the last half-year report as of 30 June 2024, the following resources were available in the liquidity account:
Get the latest news
delivered to your inbox
Sign up for The Manila Times newsletters
By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.
- Cash: € 285,764.46
- Number of shares: 129,659
- Number of executions on buy side on semester: 1,886
- Number of executions on sell side on semester: 1,610
- Trade volume on buy side on semester: 322,578 shares for € 1,074,534.26
- Traded volume on sell side on semester: 276,147 shares for € 938,985.90
When the contract was initially implemented, the following resources were included in the liquidity account:
- Cash: € 163,510.42
- Number of shares: 34,063
Buy Side | Sell Side | |||||||||||||
| Number of executions | Number of shares | Traded volume in EUR | Number of executions | Number of shares | Traded volume in EUR | ||||||||
Total | 1,281 | 215,444 | 477,452.69 | 1,366 | 231,651 | 538,913.35 | ||||||||
07/01/2024 | 10 | 1,748 | 4,754.56 | 10 | 1,500 | 4,200.00 | ||||||||
07/02/2024 | 5 | 750 | 2,085.00 | 3 | 750 | 2,100.00 | ||||||||
07/03/2024 | 14 | 1,750 | 4,847.50 | 7 | 1,250 | 3,500.00 | ||||||||
07/04/2024 | 10 | 1,751 | 4,850.27 | 7 | 1,208 | 3,358.24 | ||||||||
07/05/2024 | 9 | 1,250 | 3,487.50 | 12 | 2,243 | 6,280.40 | ||||||||
07/08/2024 | 45 | 9,505 | 22,716.95 | 23 | 3,419 | 8,376.55 | ||||||||
07/09/2024 | 9 | 1,996 | 4,910.16 | 16 | 2,831 | 7,020.88 | ||||||||
07/10/2024 | 33 | 4,849 | 11,637.60 | 8 | 1,500 | 3,735.00 | ||||||||
07/11/2024 | 14 | 2,750 | 6,600.00 | 31 | 5,750 | 14,087.50 | ||||||||
07/12/2024 | 6 | 1,100 | 2,805.00 | 25 | 4,366 | 11,264.28 | ||||||||
07/15/2024 | 11 | 4,150 | 10,416.50 | 6 | 984 | 2,587.92 | ||||||||
07/16/2024 | 23 | 5,500 | 12,925.00 | 6 | 1,000 | 2,450.00 | ||||||||
07/17/2024 | 12 | 3,570 | 8,425.20 | 6 | 1,500 | 3,585.00 | ||||||||
07/18/2024 | 1 | 1 | 2.42 | 28 | 6,751 | 16,674.97 | ||||||||
07/19/2024 | - | - | - | 7 | 1,779 | 4,500.87 | ||||||||
07/22/2024 | 8 | 1,350 | 3,361.50 | 1 | 250 | 625.00 | ||||||||
07/23/2024 | 17 | 3,501 | 8,507.43 | 8 | 1,497 | 3,697.59 | ||||||||
07/24/2024 | 23 | 4,050 | 9,598.50 | 3 | 317 | 767.14 | ||||||||
07/25/2024 | 32 | 5,101 | 11,477.25 | 1 | 1 | 2.35 | ||||||||
07/26/2024 | 13 | 2,250 | 5,107.50 | 22 | 5,283 | 12,362.22 | ||||||||
07/29/2024 | 21 | 2,361 | 5,217.81 | - | - | - | ||||||||
07/30/2024 | 7 | 1,640 | 3,575.20 | 9 | 2,000 | 4,420.00 | ||||||||
07/31/2024 | 8 | 1,751 | 3,887.22 | 14 | 2,001 | 4,502.25 | ||||||||
08/01/2024 | 23 | 3,849 | 8,313.84 | 3 | 251 | 542.16 | ||||||||
08/02/2024 | 7 | 1,500 | 3,195.00 | 9 | 1,750 | 3,762.50 | ||||||||
08/05/2024 | 15 | 2,750 | 5,802.50 | 1 | 250 | 537.50 | ||||||||
08/06/2024 | 9 | 1,295 | 2,693.60 | 7 | 639 | 1,341.90 | ||||||||
08/07/2024 | 4 | 705 | 1,466.40 | 18 | 2,640 | 5,623.20 | ||||||||
08/08/2024 | 3 | 569 | 1,223.35 | 7 | 617 | 1,332.72 | ||||||||
08/09/2024 | 5 | 973 | 2,091.95 | 11 | 1,151 | 2,509.18 | ||||||||
08/12/2024 | 19 | 3,708 | 7,786.80 | - | - | - | ||||||||
08/13/2024 | 11 | 1,750 | 3,622.50 | 6 | 523 | 1,098.30 | ||||||||
08/14/2024 | 8 | 1,750 | 3,605.00 | 1 | 42 | 87.36 | ||||||||
08/15/2024 | 4 | 730 | 1,518.40 | 16 | 2,129 | 4,449.61 | ||||||||
08/16/2024 | 6 | 870 | 1,818.30 | 9 | 402 | 848.22 | ||||||||
08/19/2024 | 1 | 70 | 151.20 | 31 | 5,816 | 12,795.20 | ||||||||
08/20/2024 | 1 | 9 | 20.25 | 12 | 1,886 | 4,281.22 | ||||||||
08/21/2024 | 8 | 2,000 | 4,640.00 | 19 | 2,969 | 6,947.46 | ||||||||
08/22/2024 | 7 | 1,250 | 2,850.00 | - | - | - | ||||||||
08/23/2024 | 8 | 1,251 | 2,839.77 | 6 | 501 | 1,147.29 | ||||||||
08/26/2024 | 15 | 3,491 | 7,784.93 | 9 | 787 | 1,794.36 | ||||||||
08/27/2024 | 4 | 1,000 | 2,210.00 | 7 | 928 | 2,078.72 | ||||||||
08/28/2024 | 11 | 1,250 | 2,750.00 | 1 | 250 | 552.50 | ||||||||
08/29/2024 | 12 | 1,302 | 2,838.36 | 6 | 334 | 731.46 | ||||||||
08/30/2024 | 9 | 746
This website uses cookies. By continuing to browse the website, you are agreeing to our use of cookies. Read More. |